356 Results for "

HDAC1

" in MedChemExpress (MCE) Product Catalog:
Products (356)

356 Results for "HDAC1" in MCE Product Catalog:

  • Isoforms Recommended:
  • Targets Recommended:
195
195 Publications Verification
Cat. No.: HY-15144
CAS No.: 58880-19-6
Purity:  99.53%
Synonyms: TSA
Trichostatin A (TSA) is a potent and specific inhibitor of HDAC class I/II, with an IC50 value of 1.8 nM for HDAC .
loading...
    loading...
171
171 Cited Publications
Cat. No.: HY-10221
CAS No.: 149647-78-9
Purity:  99.58%
Synonyms: SAHA; Suberoylanilide hydroxamic acid
Research Areas:  

Infection Cancer

Vorinostat (SAHA) is a potent and orally active pan-inhibitor of HDAC1, HDAC2 and HDAC3 (Class I), HDAC6 and HDAC7 (Class II) and HDAC11 (Class IV), with ID50 values of 10 nM and 20 nM for HDAC1 and HDAC3, respectively. Vorinostat induces cell apoptosis [1] . Vorinostat is also an effective inhibitor of human papillomaviruse (HPV)-18 DNA amplification .
loading...
    loading...
91
91 Cited Publications
Cat. No.: HY-12163
CAS No.: 209783-80-2
Purity:  99.82%
Synonyms: MS-275; SNDX-275
Target:  

HDAC Autophagy Apoptosis

Research Areas:  

Cancer

Entinostat is an oral and selective class I HDAC inhibitor, with IC50s of 243 nM, 453 nM, and 248 nM for HDAC1, HDAC2, and HDAC3, respectively.
loading...
    loading...
75
75 Cited Publications
Cat. No.: HY-15149
CAS No.: 128517-07-7
Purity:  99.87%
Synonyms: FK 228; FR 901228; NSC 630176
Target:  

HDAC Apoptosis

Research Areas:  

Cancer

Romidepsin (FK 228) is a Histone deacetylase (HDAC) inhibitor with anti-tumor activities. Romidepsin (FK 228) inhibits HDAC1, HDAC2, HDAC4, and HDAC6 with IC50s of 36 nM, 47 nM, 510 nM and 1.4 μM, respectively [1]. Romidepsin (FK 228) is produced by Chromobacterium violaceum, induces cell G2/M phase arrest and apoptosis .
loading...
    loading...
69
69 Cited Publications
Cat. No.: HY-10585
CAS No.: 99-66-1
Purity:  99.19%
Synonyms: VPA; 2-Propylpentanoic acid; Dipropylacetic acid
Valproic acid (VPA) is an orally active HDAC inhibitor, with IC50 in the range of 0.5 and 2 mM. Valproic acid inhibits HDAC1 (IC50, 400 μM), and induces proteasomal degradation of HDAC2. Valproic acid activates Notch1 signaling and inhibits proliferation in small cell lung cancer (SCLC) cells. Valproic acid is used in the epilepsy, bipolar disorder, metabolic disease, HIV infection and prevention of migraine headaches [1] .
loading...
    loading...
69
69 Cited Publications
Cat. No.: HY-10585A
CAS No.: 1069-66-5
Purity:  98.14%
Synonyms: Sodium Valproate; VPA sodium; 2-Propylpentanoic acid sodium
Valproic acid (Sodium Valproate) sodium is an orally active HDAC inhibitor, with IC50 in the range of 0.5 and 2 mM, also inhibits HDAC1 (IC50, 400 μM), and induces proteasomal degradation of HDAC2. Valproic acid sodium activates Notch1 signaling and inhibits proliferation in small cell lung cancer (SCLC) cells. Valproic acid sodium is used in the treatment of epilepsy, bipolar disorder, metabolic disease, HIV infection and prevention of migraine headaches [1] .
loading...
    loading...
47
47 Cited Publications
Cat. No.: HY-16026
CAS No.: 1316214-52-4
Synonyms: ACY-1215; Rocilinostat
Target:  

HDAC Apoptosis

Research Areas:  

Cancer

Ricolinostat (ACY-1215) is a potent and selective HDAC6 inhibitor, with an IC50 of 5 nM. ACY-1215 also inhibits HDAC1, HDAC2, and HDAC3 with IC50s of 58, 48, and 51 nM, respectively.
loading...
    loading...
40
40 Cited Publications
Cat. No.: HY-N0141
CAS No.: 20554-84-1
Synonyms: (-)-Parthenolide
Parthenolide is a sesquiterpene lactone found in the medicinal herb Feverfew. Parthenolide exhibits anti-inflammatory activity by inhibiting NF-κB activation; also inhibits HDAC1 protein without affecting other class I/II HDACs.
loading...
    loading...
36
36 Cited Publications
Cat. No.: HY-109015
CAS No.: 1616493-44-7
Purity:  98.60%
Synonyms: Chidamide; HBI-8000; CS 055
Target:  

HDAC

Research Areas:  

Cancer

Tucidinostat (Chidamide) is a potent and orally bioavailable HDAC enzymes class I (HDAC1/2/3) and class IIb (HDAC10) inhibitor, with IC50s of 95, 160, 67 and 78 nM, less active on HDAC8 and HDAC11 (IC50s, 733 nM, 432 nM, respectively), and shows no effect on HDAC4/5/6/7/9 [1].
loading...
    loading...
31
31 Cited Publications
Cat. No.: HY-18998
CAS No.: 1418033-25-6
Target:  

HDAC

Research Areas:  

Cancer

LMK-235 is a potent and selective HDAC4/5 inhibitor, inhibits HDAC5, HDAC4, HDAC6, HDAC1, HDAC2, HDAC11 and HDAC8, with IC50s of 4.22 nM, 11.9 nM, 55.7 nM, 320 nM, 881 nM, 852 nM and 1278 nM, respectively, and is used in cancer research.
loading...
    loading...
25
25 Cited Publications
Cat. No.: HY-13428
CAS No.: 537049-40-4
Purity:  99.54%
Research Areas:  

Cancer

Tubacin is a potent and selective inhibitor of HDAC6, with an IC50 value of 4 nM and approximately 350-fold selectivity over HDAC1. Tubacin also inhibits metallo-β-lactamase domain-containing protein 2 (MBLAC2).
loading...
    loading...
25
25 Cited Publications
Cat. No.: HY-12164
CAS No.: 726169-73-9
Purity:  99.13%
Synonyms: MGCD0103
Target:  

HDAC Autophagy Apoptosis

Research Areas:  

Cancer

Mocetinostat (MGCD0103) is a potent, orally active and isotype-selective HDAC (Class I/IV) inhibitor with IC50s of 0.15, 0.29, 1.66 and 0.59 μM for HDAC1, HDAC2, HDAC3 and HDAC11, respectively. Mocetinostat shows no inhibition on HDAC4, HDAC5, HDAC6, HDAC7, or HDAC8.
loading...
    loading...
18
18 Cited Publications
Cat. No.: HY-15433
CAS No.: 875320-29-9
Purity:  99.71%
Synonyms: JNJ-26481585
Target:  

HDAC Autophagy

Research Areas:  

Inflammation/Immunology Cancer

Quisinostat (JNJ-26481585) is a potent and orally active pan-HDAC inhibitor (HDACi), with IC50 values ranging from 0.11 nM to 0.64 nM for HDAC1, HDAC2, HDAC4, HDAC10 and HDAC11. Quisinostat has a broad spectrum antitumoral activity [1]. Quisinostat can induce autophagy in neuroblastoma cells .
loading...
    loading...
18
18 Cited Publications
Cat. No.: HY-15433A
CAS No.: 875320-31-3
Purity:  99.05%
Synonyms: JNJ-26481585 dihydrochloride
Target:  

HDAC Autophagy

Research Areas:  

Inflammation/Immunology Cancer

Quisinostat dihydrochloride (JNJ-26481585 dihydrochloride) is an orally active, potent pan-HDAC inhibitor with IC50s of 0.11 nM, 0.33 nM, 0.64 nM, 0.46 nM, and 0.37 nM for HDAC1, HDAC2, HDAC4, HDAC10 and HDAC11, respectively. Quisinostat dihydrochloride has a broad spectrum antitumoral activity. Quisinostat dihydrochloride can induce autophagy in neuroblastoma cells [1] .
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-13522
CAS No.: 1339928-25-4
Purity:  99.95%
Synonyms: CUDC-907
Target:  

PI3K HDAC Apoptosis

Research Areas:  

Cancer

Fimepinostat (CUDC-907) potently inhibits class I PI3Ks as well as classes I and II HDAC enzymes with an IC50 of 19/54/39 nM and 1.7/5.0/1.8/2.8 nM for PI3Kα/PI3Kβ/PI3Kδ and HDAC1/HDAC2/HDAC3/HDAC10 , respectively.
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-16425
CAS No.: 1215493-56-3
Synonyms: RGFP109
Target:  

HDAC

Research Areas:  

Cancer

RG2833 is a brain-penetrant HDAC inhibitor with IC50s of 60 nM and 50 nM for HDAC1 and HDAC3, respectively. The Ki values for HDAC1 and HDAC3 are 32 and 5 nM, respectively [1].
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-14842B
CAS No.: 732302-99-7
Purity:  98.06%
Synonyms: ITF-2357 hydrochloride monohydrate
Givinostat hydrochloride monohydrate (ITF-2357 hydrochloride monohydrate) is a HDAC inhibitor with an IC50 of 198 and 157 nM for HDAC1 and HDAC3, respectively. Givinostat hydrochloride monohydrate can penetrate the blood-brain barrier (BBB) [1] .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-14842A
CAS No.: 199657-29-9
Purity:  98.06%
Synonyms: ITF-2357 hydrochloride
Target:  

HDAC

Research Areas:  

Inflammation/Immunology Cancer

Givinostat (ITF-2357) hydrochloride is a HDAC inhibitor with an IC50 of 198 and 157 nM for HDAC1 and HDAC3, respectively. Givinostat hydrochloride can penetrate the blood-brain barrier (BBB). [1] .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-14842
CAS No.: 497833-27-9
Purity:  98.67%
Synonyms: ITF-2357
Target:  

HDAC

Research Areas:  

Inflammation/Immunology Cancer

Givinostat (ITF-2357) is a HDAC inhibitor with an IC50 of 198 and 157 nM for HDAC1 and HDAC3, respectively. Givinostat can be used for Duchenne muscular dystrophy (DMD) research. Givinostat can penetrate the blood-brain barrier (BBB) [1] .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-50934
CAS No.: 112522-64-2
Synonyms: N-acetyldinaline; CI-994; Goe-5549
Target:  

HDAC Apoptosis

Research Areas:  

Cancer

Tacedinaline (N-acetyldinaline) is an inhibitor of the histone deacetylase (HDAC) with IC50s of 0.9, 0.9, 1.2 μM for recombinant HDAC 1, 2 and 3 respectively.
loading...
    loading...